OBJECTIVE - To compare the short-term oncological and HRQOL outcomes between open (ORP) and robotic-assisted (RARP) radical prostatectomy in the population-based Victorian Prostate Cancer Registry (PCR).
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
PATIENTS AND METHODS - This is a prospective cohort of prostate cancer patients who had RP (1117 ORP and 885 RARP) between January 2009 and June 2012.
The oncological outcomes of interest were: positive surgical margin (PSM) and biochemical recurrence (BCR) (defined as post-operative PSA >0. 2ng/ml). The HRQOL outcomes were: sexual and urinary bother, assessed using the Expanded Prostate Cancer Index Composite (EPIC) at 1- and 2-year post-diagnosis. Student T-test or Mann-Whitney U-test were used for univariate comparison of continuous variables, and Pearson's chi-squared test for categorical variables. Bonferonni correction was applied to account for multiple testing, with threshold for significance of P
RESULTS - ORP and RARP patients were followed for a median of 19 months and 17 months respectively. The proportion of patients with NCCN low risk prostate cancer was significantly higher among RARP patients (21% vs. 26%; P=0. 002). The majority of RP was done in the private sector (77% ORP, and 85% RARP, P20 case/ year (P
CONCLUSIONS - We reported a large population-based comparative study on ORP and RARP with better short-term oncological outcomes favouring RARP, but no significant differences in HRQOL outcomes. The results have to be interpreted, taking into account significant surgeon heterogeneity, in a population-based study. This article is protected by copyright. All rights reserved.
BJU international. 2015 Nov 17 [Epub ahead of print]
Wee Loon Ong, Sue M Evans, Tim Spelman, Paul A Kearns, Declan G Murphy, Jeremy L Millar
Department of Urology, Alfred Health, Monash University. , Department of Epidemiology and Preventive Medicine, Monash University. , Department of Epidemiology and Preventive Medicine, Monash University. , Department of Urology, Barwon Health. , Division of Cancer Surgery Peter MacCallum Cancer Centre. , Department of Epidemiology and Preventive Medicine, Monash University.